Abstract

Canine cutaneous mast cell tumors (MCT) are the lethal skin tumors. The biological behavior of the MCT cells is quite varied and unpredictable. Almost MCT dogs usually require a rapid diagnosis and therapy. However, MCT diagnosis and prognosis are still dependent on histopathology which is rather inconvenient, time-consuming, painful, and harmful for some cases. Indeed, MCT can be easily accessible using fine-needle aspiration (FNA). In this study, our biopsy specimens were classified as low- and high-grade MCT based on the novel 2-tier histopathologic grading system. We have demonstrated the usage of fine-needle aspirated MCT cells (FNA-MCT cells) from these specimens as a primary cell source to study the distribution of CD117-immunocytochemistry (CD117-ICC) staining patterns and the frequency of internal tandem duplication- (ITD-) mutant exon-11 of c-kit. The result has substantially shown that there were three staining patterns identified in the cells. Only paranuclear pattern was significantly increased in the cells from high-grade MCT. Altogether, the ITD-mutant exon-11 was also detectable only in these cells. Therefore, the result has supported our hypothesis that there was an increased opportunity to observe a higher CD117-ICC staining pattern and exon-11 mutation in high-grade MCT; even these two parameters may not precisely indicate a histopathological grade.

Highlights

  • Canine cutaneous mast cell tumors (MCT) are the secondmost prevalent life-threatening skin tumor of dogs

  • In our recent study, the central questions were “Can fine-needle aspiration (FNA)-MCT cells represent a good cell source for studying MCT biology behavior?” “Can we evaluate the distribution frequency of a CD117-immunolabeling pattern and mutant exon-11 using these cells?” and “Do these two parameters have any interconnection?” We hypothesized that FNA-MCT cells were the good representative for all MCT cells from tissue-based specimens graded by the novel 2tier histopathologic grading system

  • The result consistently exhibited the persistence of MCT cells in each FNA sample

Read more

Summary

Introduction

Canine cutaneous mast cell tumors (MCT) are the secondmost prevalent life-threatening skin tumor of dogs. MCT diagnosis is currently based upon Patnaik’s MCT histopathologic grading system. This method provides much more useful information on MCT diagnosis, grading, prognosis, and therapeutic planning. Grounded on this system, MCT could be classified into grades I, II, or III depending on each corresponding histopathologic morphology [4]. A novel MCT-histopathologic grading system, has been introduced into the veterinary pathology field. This 2-tier histopathologic grading classifies MCT into 2 groups: low-grade and high-grade MCT. This system has improved the concordance among veterinary pathologists on MCT grading and the relevance to survival time, when compared to the conventional Patnaik’s grading system [5]

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call